Mark A. Meltz - COO GENERAL COUNSEL SECRETARY at Kinnate Biopharma Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Coo General Counsel Secretary
Stock Symbol
KNTE
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark A. Meltz since 11/8/2023

Holdings reported by Mark A. Meltz for Kinnate Biopharma Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 0 $0 $2.59 Apr 3, 2024 Direct
Stock Option (right to buy) 0 Apr 3, 2024 Direct Common Stock

Transactions reported by Mark A. Meltz for Kinnate Biopharma Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.